The National Institute for Health and Clinical Excellence has issued an update to the Lipid Modification Guideline relating to recommendations on methods of cardiovascular risk estimation.
The original guideline recommended using a Framingham based risk estimation tool however recent developments in the evidence comparing different risk estimation tools has resulted in no single tool having a clear advantage.
Action: Clinicians should be aware of this update and consider which risk prediction tool should be used in practice. Whichever tool is used, clinicians should be aware of any limitations and corrections required in use.
|« Drug Safety Update - April 2010||SMC Update - April 2010 »|